Dual-listed cervical cancer screening device company TruScreen has appointed Dr Beata Edling as chief executive.
She joined TruScreen in October 2020 as Medical Affairs and Market Access Lead and helped the company gain access into new markets in eastern Europe and the Balkan nations. She’s also
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
